Radiopharmaceutical Theranostics Market
Radiopharmaceutical Theranostics Market Research Report By Application (Oncology, Cardiology, Neurology, Endocrinology), By Radioisotope (Fluorine-18 (18F), Carbon-11 (11C), Nitrogen-13 (13N), Gallium-68 (68Ga)), By Modality (PET (Positron Emission Tomography), SPECT (Single-Photon Emission Computed Tomography), SPECT/CT (Single-Photon Emission Computed Tomography/Computed Tomography), PET/CT (Positron Emission Tomography/Computed Tomography)), By Target Disease (Cancer, Cardiovascular Disease, Neurological Disorders, Endocrine Disorders) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global Radiopharmaceutical Theranostics Market Overview:
As per MRFR analysis, the Radiopharmaceutical Theranostics Market Size was estimated at 1.94 (USD Billion) in 2023. The Radiopharmaceutical Theranostics Market Industry is expected to grow fr..